World Veterinary Vaccine Congress: Industry Insights

The veterinary vaccines market is becoming increasingly important and growing in a way we haven’t seen before. With issues such as an increased focus on zoonotic infectious diseases jumping to humans, the impact of disease on livestock of economic importance and the increase in interest in companion diseases, it is clear why veterinary vaccines are coming into the limelight. With our World …

Novartis vaccine Bexsero sees high uptake in first large-scale public vaccination program to help protect against devastating meningitis B

July 29th, 2014 Program in Québec’s Saguenay-Lac-Saint-Jean region is the first public campaign globally to offer Bexsero to all from 2 months to 20 years of age More than 45,000 infants, young children and adolescents included in the program have already received at least one dose of Bexsero Swift implementation, within 6 months of approval, marks a milestone in helping …

vaccine manufacturers

Top 3 Sparks of Interest for Leading Vaccine Academics

Recently we undertook the research for the 15th annual World Vaccine Congress. As part of that research, we spoke to leading vaccine academics from the likes of University of Oxford and Erasmus MC to find out what they thought were the most interesting trends in industry at the moment. These were the top 3: 1. The renaissance of veterinary vaccines …

Mass Immunization of Polio

Mass Immunization Of Polio

Immunization Program Begins In Kurdistan Relief agencies and partners of the UN have increased healthcare efforts in Iraq, starting with a massive polio vaccination campaign in the capital of Baghdad. As well as an initiative aimed at improving healthcare in Kurdistan. According to a UN World Health Organization representative, the agencies are working closely with UNICEF to vaccinate as many …

Vaccine Asia Live: Forging Partnerships for Improved Immunisation in Laos

“Vaccination as the most cost-efficient method to save millions of lives around the world.” To kick-start the 2nd day’s activities for World Vaccine Congress Asia 2014, we have the privilege and honour in having Dr Bounkong Syhavong, the Vice Minister of Health for Lao People’s Democratic Republic to present on the forging of partnerships for improved immunisation in Laos. For the …

Vaccine

Vaccine Asia Live: Novel Vaccines for Emerging Diseases

Most vaccines developed target infectious diseases and cancer, with cancer vaccines being listed more under therapeutic vaccines. To enlighten us on vaccines for infectious diseases, Ms Zhang Xiaoshu, Director of Business Development at BravoBio, China, presented on the topic of Novel Vaccines for Emerging Diseases. BravoBio was founded in 2011 with its  headquarters in Shanghai and multiple sites in China. …

Vaccine Asia Live: Recombinant Lipoimmunogen-based therapeutic HPV Vaccine

Human Papilloma Virus(HPV) is a DNA virus that can cause skin & genital warts as well as cervical and osopharyngeal cancers. In the US, there is an increasing trend in cervical cancer in women and osopharyngeal cancer in men.  To make things worse, there are no treatments available for HPV infection. Thus, HPV vaccines have become the most common mode …

Vaccine Asia Live: Forging Strategic Partnership for R&D to Meet High Demands for Vaccines in Asia

As a unique feature of Terrapinn conferences, the roundtable discussions serve as an interactive platform for meaningful discussion. At World Vaccine Congress Asia 2014, Do Tuan Dat, President & General Director of Vabiotech, Vietnam, moderated the discussion on the topic of “Forging Strategic Partnership for R&D to Meet High Demands for Vaccines in Asia”. A consensus was reached among the …

Vaccine Asia Live: Accelerating Vaccine Development in Asia through Public-Private Partnership(PPP)

Live at World Vaccine Congress Asia 2014, the day was opened with a panel discussion on accelerating vaccine deelopment in Asia through Public-Private Partnerships(PPP). Andrew Potter, CEO of PREVENT Canada moderated the discussion with Lanling Zou of NIAID USA, Duane Gubler of SUKW-NUS Graduate Medical School Singapore  and Stephen Cook of GSK Belgium. It was a great start to a …